Items where authors include "Shijie (Kate), Ren"

Article

Woods, Beth orcid.org/0000-0002-7669-9415, Kearns, Ben, Schmitt, Laetitia Helene Marie orcid.org/0000-0003-1052-488X et al. (15 more authors) (2024) Assessing the Value of New Antimicrobials:Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England. Applied Health Economics and Health Policy. ISSN 1175-5652

Woods, Beth orcid.org/0000-0002-7669-9415, Schmitt, Laetitia Helene Marie orcid.org/0000-0003-1052-488X, Jankovic, Dina orcid.org/0000-0002-9311-1409 et al. (10 more authors) (2024) Cefiderocol for treating severe aerobic Gram-negative bacterial infections:technology evaluation to inform a novel subscription-style payment model. Health technology assessment. pp. 1-238. ISSN 2046-4924

Bojke, Laura orcid.org/0000-0001-7921-9109, Manca, Andrea orcid.org/0000-0001-8342-8421, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (3 more authors) (2017) How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. Pharmacoeconomics. pp. 1-10. ISSN 1179-2027

Jackson, Christopher, Stevens, John, Shijie (Kate), Ren et al. (4 more authors) (2017) Extrapolating survival from randomised trials using external data:a review of methods. Medical Decision Making. 377–390. ISSN 1552-681X